Riskpilot← Back to searchSign inGet full accessArtem Dental Lab AB
ABActiveOrg 5591988299Gimogatan 2 BManufacture of medical and dental instruments and supplies · NACE 3250Est. 20195 employees
Revenue 2025
SEK 4M
+13% vs 2024
EBITDA margin
4.9%
-67% vs 2024
Equity ratio
42.4%
Financial strength
Net profit 2025
SEK 73K
-75% vs 2024
| Revenue | SEK 4M | +13% |
| EBITDA | SEK 196K | -67% |
| Net profit | SEK 73K | -75% |
| Total assets | SEK 1,4M | -9% |
| Equity | SEK 574K | -36% |
| Employees | 5 | — |
Legal name
Artem Dental Lab AB
Org number
5591988299
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
15 mars 2019
Share capital
SEK 50 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva tandtekniskt laboratorium samt därmed förenlig verksamhet.
Address
Gimogatan 2 B
Email
artem.dentallab@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 706 | 1 837 | 3 316 | 3 523 | 3 982 |
| Staff expenses | — | −588 | −1 206 | −1 581 | −1 997 |
| EBITDA | 702 | 148 | 863 | 585 | 196 |
| Depreciation & amort. | −50 | −50 | −130 | −100 | −93 |
| EBIT | 652 | 98 | 733 | 486 | 103 |
| Net financials | — | −0 | 5 | 7 | −1 |
| Profit before tax | 548 | 98 | 563 | 366 | 103 |
| Tax | −64 | −21 | −118 | −78 | −30 |
| Net profit | 484 | 76 | 446 | 287 | 73 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 830 | 878 | 1 422 | 1 490 | 1 354 |
| Equity | 542 | 618 | 864 | 901 | 574 |
| Long-term debt | 42 | 0 | 0 | 6 | 6 |
| Short-term debt | 142 | 156 | 280 | 178 | 369 |
| Total debt | 184 | 156 | 280 | 183 | 375 |
EBITDA margin
4.9%
This company
15.8%
Market median
-69% vs market
20212025
Equity ratio
42.4%
This company
38.2%
Market median
+11% vs market
20212025
Return on equity
12.7%
This company
18.4%
Market median
+31% vs market
20212025
Net profit margin
1.8%
This company
8.1%
Market median
-78% vs market
20212025
Asset turnover
2.94×
This company
1.12×
Market median
+162% vs market
20212025
Debt / equity
1.36×
This company
0.62×
Market median
-119% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MD Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
AD Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Artem Dental Lab AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ahmad Dawalibi | Chief Executive Officer | 0 companies |
| Mostafa Dawalibi | Chief Executive Officer | 0 companies |
| Abdullah Dawalibi | Deputy Board Member | 0 companies |